Nunzia Pharmaceutical Company (NUNZ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 21, 2026

NUNZ Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Sep '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Net Income
-96.99-78.06-101.02-0.03-0.02-0.01
Stock-Based Compensation
96.75780---
Other Operating Activities
0-100.98--0.01-
Change in Accounts Payable
0.03-0.0200.0100.01
Change in Other Net Operating Assets
0--0.020.030
Operating Cash Flow
-0.2-0.09-0.03-0--
Short-Term Debt Issued
-0.090.01---
Long-Term Debt Issued
--0.02---
Total Debt Issued
0.10.090.03---
Net Debt Issued (Repaid)
0.10.090.03---
Issuance of Common Stock
0.14--0--
Financing Cash Flow
0.230.090.030--
Net Cash Flow
0.030----
Levered Free Cash Flow
36.09-----
Unlevered Free Cash Flow
36.09-----
Change in Working Capital
0.04-0.0200.030.030.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.